Skip to main content
Gopal Gupta, MD, Urology, Maywood, IL

GopalN.GuptaMDFACS(He/Him)

Urology Maywood, IL

Minimally Invasive Surgery, Surgical Oncology

Professor of Urology/Surgery/Radiology, Fellowship Director Urologic Oncology

Dr. Gupta is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Gupta's full profile

Already have an account?

  • Office

    2160 S 1st Ave
    Fahey Center, Bldg 54
    Maywood, IL 60153
    Phone+1 708-216-5098

Summary

  • Dr. Gupta received his B.S. (Biological Chemistry) from the University of Chicago in 1996. He received his M.D. from the University of Illinois at Chicago in 2002. He then performed his residency in urologic surgery at the University of Maryland Medical Center (2002-2008). He continued his training as a fellow in Urologic Oncology at the National Cancer Institute (NIH) in the Urologic Oncology Branch under the guidance of Dr. W. Marston Linehan (2008-2011). In 2011 he was recruited to the Department of Urology by Dr. Robert Flanigan as a fellowship trained urologic oncologist. Dr. Gupta holds a primary appointment in the Department of Urology, and has a joint appointment in the Department of Surgery and the Oncology Institute.

    His primary clinical research interests pertain to bladder, kidney and prostate cancer. Dr. Gupta performs minimally invasive surgeries using the DaVinci Robotic Surgery platform. His clinical interests are to push the cutting edge of technology while optimizing cancer outcomes. He is also interested in the role of targeted therapies either before or after surgery to enhance cancer outcomes.

    Dr. Gupta’s laboratory is located in the oncology institute. He has been named a Dean’s Office Clinical Scholar and splits his time between his clinical responsibilities and his research interests. His laboratory is active in creating pre-clinical models in bladder and kidney cancer to assess the effects of emerging targeted therapies.

    Dr. Gupta has positioned Loyola to be a leader in robotic surgery and cutting edge urologic cancer surgery treatments. He has developed novel robotic approaches to kidney cancer surgery, prostate cancer and bladder cancer surgery. In addition, he has established the first MRI guided prostate fusion biopsy program in Illinois.

    Dr. Gupta is an expert in urologic oncology and robotic surgery and lectures extensively on these subjects at the regional and national level.
  • Faster recovery from kidney tumor with Loyola's robotic surgery

    Dr. Gopal Gupta, a urologic cancer surgeon, talks about how treatment of kidney cancer once meant the whole kidney would have to be removed. But now with roboti

    UroNav fusion biopsy prostate cancer procedure at Loyola Medicine

    When Mike Marks learned he had prostate cancer, he considered several other centers before choosing Loyola Medicine. Mr. Marks was impressed with Loyola's cutti

    Loyola now offering combined MRI/ultrasound imaging for prostate cancer detectio

    Loyola is the first in Illinois to have a prostate imaging system that combines ultrasound and magnetic resonance imaging (MRI) images, which allows for a more

    Gopal Gupta, MD, FACS

    Dr. Gupta received his B.S. (Biological Chemistry) from the University of Chicago in 1996. He received his M.D. from the University of Illinois at Chicago in 20

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Minimally Invasive Urologic Surgery, 2008 - 2011
  • University of Maryland
    University of MarylandResidency, Urology, 2002 - 2008
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 2002
  • University of Chicago
    University of ChicagoBS, Biological Chemistry, 1991 - 1996
  • University of Chicago
    University of ChicagoB.S., Biological Chemistry, 1991 - 1996

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2011 - 2026
  • IN State Medical License
    IN State Medical License 2024 - 2025
  • MD State Medical License
    MD State Medical License 2008 - 2012
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • Achieved Top Stats in Department (Researchgate) 2012-2024
  • Young Career Investigator Showcase AUA, 2016
  • Best Poster NCS AUA section, 2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Postoperative Urinary Retention is an Independent Predictor of Short-Term and Long-Term Future Bladder Outlet Procedure in Men  
    Blackwell RH, Vedachalam S, Shah AS, Kothari AN, Kuo PC, Gupta GN, Turk TMT, J Urol, 1/15/2017
  • Discordance between surgical care improvement project adherence and postoperative outcomes: implications for new Joint Commission standards  
    Chang V, Blackwell RH, Markossian T, Yau RM, Blanco BA, Zapf MAC, Abood GJ, Gupta GN, Kuo PC, Kothari AN, J Surg Res, 1/1/2017
  • Re: Csaba Berczi, Ben Thomas, Zsolt Bacso, Tibor Flasko Bilateral renal cancers: oncological and functional outcomes  
    Watson MJ, Sidana A, Singer EA, Gupta GN, Rastinehad AR, Vourganti S, Bratslavsky G, Metwalli AR, Int Urol Nephrol, 1/1/2017
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Trajectories of readmission risk redefine the period of heightened vulnerability following urologic oncologic procedures.
    Zapf MAC, Blackwell RH, Hannick JH, Kothari AN, Kuo PC, Gupta GN, J Urol, 1/1/2016
  • Hospital and patient related factors influencing the utilization of partial nephrectomy.
    Shah AS, Blackwell RH, Kothari AN, Zapf MAC, Kuo PC, Gupta GN, J Urol, 1/1/2016
  • Addition of emetine dihydrochloride to platinum based chemotherapy inhibits bladder cancer cell proliferation and reduces the effective dose of platinum chemotherapy.
    Davidson VJ, Blackwell RH, Foreman KE, Kuo PC, Flanigan RC, Gupta GN, J Urol, 1/1/2016
  • Join now to see all

Lectures

  • Renal Cancer Exosomes: implications in Metastasis 
    Chicago, IL - 1/17/2016
  • Prostate Cancer Update 
    Loyola University Gottlieb Hospital, Elmwood Park, IL - 1/8/2016
  • Bladder Cancer Shed Exosomes: What do we know? 
    San Diego, CA - 1/7/2016
  • Join now to see all

Press Mentions

  • Twenty-Seven Loyola Physicians Named to Chicago Magazine's 2019 Top Cancer Doctors
    Twenty-Seven Loyola Physicians Named to Chicago Magazine's 2019 Top Cancer DoctorsNovember 6th, 2019
  • Transperineal Prostate Biopsy Minimizes Risk of Infection, May Increase Detection Rate
    Transperineal Prostate Biopsy Minimizes Risk of Infection, May Increase Detection RateSeptember 24th, 2019
  • New System Proposed for Logging Physician Experience in Robotic Surgeries
    New System Proposed for Logging Physician Experience in Robotic SurgeriesSeptember 26th, 2017
  • Join now to see all

Professional Memberships

Other Languages

  • Hindi